Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer
Study Number: 

NCG 290116

Phase: 
3
Trial categories: 
Non-Small Cell Lung Cancer (NSCLC)
Lung
Immunotherapy
Antibody therapy
Checkpoint blockade
Principal Investigator: